BBH
VanEck Biotech ETFstockNASDAQETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 254.46 | 2026-11-12 | -3.77% | 0.337 |
| 1M | 241.14 | 2026-10-19 | +1.55% | 0.907 |
| 3M | 244.02 | 2026-08-19 | +0.35% | 0.912 |
| 6M | 181.12 | 2026-05-19 | +35.20% | 0.614 |
| 1Y | 189.89 | 2025-11-19 | +28.95% | 0.713 |
| 2Y | 157.96 | 2024-11-19 | +55.02% | — |
| 5Y | 193.33 | 2021-11-19 | +26.66% | 0.784 |
VanEck Biotech ETF (NASDAQ:BBH) stock price today is $244.87, and today's volume is 17,144. BBH is down 1.173% today. The 30 day average volume is 15,533. BBH market cap is $510.92M with 2.09M shares outstanding.